Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 5/20 | 0.59 |
| ▸ | ERAP2 | Q6P179 | 5/20 | 0.59 |
| ▸ | ACE | P12821 | 2/20 | 0.55 |
| ▸ | KISS1R | Q969F8 | 6/20 | 0.55 |
| ▸ | IL1RN | P18510 | 3/20 | 0.54 |
| ▸ | ERAP1 | Q9NZ08 | 3/20 | 0.54 |
| ▸ | ANPEP | P15144 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28664025 | 1.00 | ECE1 (0.59) | ECE1ERAP2ACEKISS1RIL1RN | |
| SCHEMBL30522762 | 0.99 | ECE1 (0.58) | ECE1ERAP2ACEKISS1RIL1RN | |
| SCHEMBL31229004 | 0.98 | ERAP2 (0.62) | ECE1ERAP2ACEKISS1RIL1RN | |
| SCHEMBL29794156 | 0.96 | ERAP2 (0.55) | ECE1ERAP2ACEKISS1RIL1RN | |
| SCHEMBL30044908 | 0.96 | KISS1R (0.61) | ERAP2KISS1RIL1RN | |
| SCHEMBL29532500 | 0.93 | KISS1R (0.57) | ECE1ERAP2KISS1R | |
| SCHEMBL31484225 | 0.93 | ERAP2 (0.57) | ECE1ERAP2KISS1R | |
| SCHEMBL31232571 | 0.93 | KISS1R (0.59) | ECE1ERAP2KISS1RIL1RNERAP1 | |
| SCHEMBL29662004 | 0.92 | ACE (0.55) | ECE1ERAP2ACEERAP1 | |
| SCHEMBL29924965 | 0.92 | ACE (0.55) | ECE1ERAP2ACEERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113754718-A | Liquid phase synthesis method of tripeptide leucyl-arginyl-tryptophan | 湖北泓肽生物科技有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113754718-A | Liquid phase synthesis method of tripeptide leucyl-arginyl-tryptophan | 湖北泓肽生物科技有限公司 | 2021-12-07 | — | — | CN | disclosed |
| CN-113754718-A | Liquid phase synthesis method of tripeptide leucyl-arginyl-tryptophan | 湖北泓肽生物科技有限公司 | 2021-12-07 | — | — | CN | disclosed |
| CN-113754718-A | Liquid phase synthesis method of tripeptide leucyl-arginyl-tryptophan | 湖北泓肽生物科技有限公司 | 2021-12-07 | — | — | CN | disclosed |